RTP801 immunoreactivity in retinal ganglion cells and its down-regulation in cultured cells protect them from light and cobalt chloride  by del Olmo-Aguado, Susana et al.
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RTP801,  a stress-related  protein,  is  activated  by  adverse  environmental  conditions  and  inhibits  the  activity
of  mammalian  target  of rapamycin  (mTOR)  in promoting  oxidative  stress-dependent  cell  death.  RTP801
exists  both  in the mammalian  retina  and  the  lens of  the  eye.  Here,  we  observed  RTP801  immunoreactivity
in  some  retinal  ganglion  cells.  Intravitreal  injection  of cobalt  chloride  (CoCl2) to  mimick  hypoxia  inﬂu-
enced  retinal  GFAP  (glial ﬁbrillary  acidic  protein)  and  heme  oxygenase-1  (HO-1)  levels,  but did  not  affect
RTP801  immunoreactivity  or mRNA  content  relative  to GAPDH.  However,  RTP801  mRNA  was  elevated
when  compared  with  Brn3a  mRNA,  suggesting  that  RTP801  is  activated  in stressed  Brn3a  retinal  gan-
glion  cells.  In  cultures  of RGC-5  cells,  RTP801  immunoreactivity  was  located  in  the  cytoplasm  and  partlyhemical hypoxia
lue light
europrotection
apamycin
present  in the  mitochondria.  An  insult  of  blue  light  or CoCl2 increased  RTP801  expression,  which  was
accompanied  by cell  death.  However,  in  cultures  where  RTP801  mRNA  was  down-regulated,  the  nega-
tive  inﬂuence  of  blue  light  and  CoCl2 was  blunted.  Rapamycin  nulliﬁed  the  CoCl2-induced  up-regulation
of RTP801  and  attenuated  cell  death.  Moreover,  rapamycin  was  non-toxic  to RGC-5  cells,  even  at  a  high
concentration  (10  M). The  protective  effect  of  rapamycin  on  RGC-5  cells  caused  by the  inhibition  of
RTP801  suggests  that  rapamycin  might  attenuate  retinal  ganglion  cell death  in  situ,  as  in glaucoma.. Introduction
Studies in the past have shown that RTP801 (also referred to
s REDD1 and encoded by Ddit4) is a stress-related protein that
an regulate mammalian target of rapamycin (mTOR) and as a con-
equence, serves as a regulator of cell metabolism, proliferation
nd cell survival (Katiyar et al., 2009; Laplante and Sabatini, 2009,
012; Yoshida et al., 2010). RTP801 was initially identiﬁed as a
ene induced by DNA damage, suppressing mTOR function via a
echanism dependent on tuberous sclerosis protein 2 (Arachchige
on et al., 2012; DeYoung et al., 2008; Molitoris et al., 2011).
nduced RTP801 has been reported to promote death of post-
itotic neurons (Malagelada et al., 2008; Shoshani et al., 2002),
ut protects cells from apoptosis associated with oxidative stress
Shoshani et al., 2002). Such observations suggest that the interac-
ion of RTP801 and mTOR is complex and likely to vary in different
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ores Fernández-Vega 34, E-33012 Oviedo, Asturias, Spain.
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cell types and in deﬁned conditions. It also provides an explana-
tion as to why  rapamycin (a target for mTOR) protects neurons
from death in cellular and animal toxin models of Parkinson’s dis-
ease (Malagelada et al., 2010) and when RTP801 is knocked down
(Malagelada et al., 2006), but does not do so when mTOR  is instead
affected by the full catalytic inhibitor Torin1 (Pong and Zaleska,
2003).
It is generally thought that mTOR blockade suppresses the acti-
vation of the protein kinase Akt, which is known to have a major role
in maintaining neuronal survival (Dudek and Datta, 1997; Franke
et al., 1997a; Franke et al., 1997b). Malagelada et al. (2010) proposed
that phosphorylation of Akt at Thr308 (mimicked by rapamycin)
acts as a pro-survival stimulus, while phosphorylation of Akt at
Ser473 (mimicked by Torin1) promotes cell death. Since Akt partic-
ipates in the retinal ganglion death caused by NMDA and in animal
models of glaucoma (Levkovitch-Verbin et al., 2007; Manabe and
Lipton, 2003; Nakazawa et al., 2005), it is possible that rapamycin,
via its inﬂuence on Akt, can attenuate ganglion cell death in such
circumstances.
The relevance of RTP801 in the pathogenesis of certain human
ocular diseases has been suggested in studies utilising RTP801
knockout mice, subjecting them to hypoxia, as in retinopathy of
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Table  1
Primers used for real-time PCR.
Gene Origin Forward Reverse
ARP Mouse 5′-CGACCTGGAAGTCCAACTAC-3′ 5′-ATCTGCTGCATCTGCTTG-3′
ARP Rat 5′-TCGCCAGGCGTCCTCATTAGAGT-3′ 5′-TCTTGCCCATCAGCACCACAGC-3′
Brn3a Rat 5′-CAGGAGTCCCATGTAAGA-3′ 5′-ACAGGGAAACACTTCTGC-3′
GAPDH Mouse 5′-CAACGGGAAGCCCATCAC-3′ 5′-CGGCCTCACCCCATTTG-3′
GAPDH Rat 5′-TGCCACTCAGAAGACTGTGGATG-3′ 5′-GCCTGCTTCACCACCTTCTTGAT-3′
GFAP Rat 5′-TGGCCACCAGTAACATGCAA-3′ 5′-CAGTTGGCGGCGATAGTCAT-3′
HO-1 Rat 5′-CAGCCCCAAATCCTGCAACAGA-3′ 5′-CAACATGGACGCCGACTACCAA-3′
′ GAAC ′ ′ ′
AAGA
CAGC
p
a
c
t
o
e
R
i
(
b
t
e
r
s
e
t
r
m
g
w
t
5
(
c
t
h
t
g
2
2
c
A
D
1
i
a
f
p
c
P
w
R
F
(
a
a
omTOR Mouse 5 -GGCAGGAT
RTP801 Mouse 5′-GCCGGAGG
RTP801 Rat 5′-CTGGCGTA
rematurity (Brafman et al., 2004). RTP801-deﬁcient mice have
 decreased level of neovascularization and retinal pathological
hanges are reduced compared to wild-type mice. This shows that
he development of retinopathy in a mouse model of retinopathy
f prematurity is signiﬁcantly attenuated in the absence of RTP801
xpression. Moreover, in situ hybridisation has shown that low
TP801 hybridisation signals exist in all retinal layers, but increase
n the outer part of the inner retinal layer following hypoxia
Brafman et al., 2004). This implies that RTP801 expression may
e present in cellular and/or vascular components associated with
he outer portion of the inner nuclear layer. Signiﬁcantly, Dejneka
t al. (2004) demonstrated that systemic rapamycin inhibited
etinal and choroidal neovascularization in mice, which is con-
istent with the known negative effect of rapamycin on RTP801
xpression.
In the present study, we observed that RTP801 immunoreac-
ivity was particularly pronounced in the ganglion cells of rodent
etinas. This implies that RTP801 may  play a role in the develop-
ent of certain optic neuropathies involving the death of retinal
anglion cells. We  therefore decided to investigate whether RTP801
as involved in the maintenance of cells in culture as a prelude
o future studies on retinal ganglion cells in situ. We  used RGC-
 cells, which have some characteristics of retinal ganglion cells
Krishnamoorthy et al., 2001), and determined how RTP801 and
ell survival were affected by blue light or CoCl2, which were used
o simulate hypoxia. These insults were chosen because we  have
ypothesised that the blue light component of visual light entering
he eye and hypoxia/ischaemia participate in the pathogenesis of
laucoma (see Osborne, 2010).
. Materials and methods
.1. Materials
A transformed cell line (RGC-5 cells) with some ganglion cell
haracteristics (Krishnamoorthy et al., 2001) was used in this study.
nti-RTP801 was purchased from ProScience, anti-GFAP from
akoCytomation, anti-actin from Millipore, anti-heme oxgenase-
 (HO-1) from Enzo Life Sciences, anti-Brn3a and anti-apoptosis
nducing factor (AIF) from Santa Cruz Biotechnology (CA, USA), and
nti-OXPHOS (Mito-Proﬁle total antibody cocktail) was obtained
rom MitoSciences. The apoptosis assay (APOPercentage) used was
urchased from Biocolor (Carrickfergus,UK). PureLink RNA puriﬁ-
ation kit was from Ambion, Life Technologies. Power SYBR Green
CR Master Mix  and High Capacity RNA-to-cDNA Master Mix
ere from Applied Biosystems (California, USA). Lipofectamine
NAiMAX and OPTIMEM medium, foetal bovine serum, DAPI, Alexa
luor 488, DHE, penicillin, and streptomycin were from Invitrogen
Paisley, UK). CCCP (carbonyl cyanide 3-chlorophenylhydrazone),
s well as the other chemicals and reagents were gener-
lly from Sigma–Aldrich (St. Louis, MO,  USA), unless indicated
therwise.GAGTGATG-3 5 -CCGAGTTGGTGGACAGAGG-3
CTCCTCAT-3′ 5′-GCTGCATCAGGTTGGCACAC-3′
GAGCCGTG-3′ 5′-TGGGCCAGAGGCGAGAGTCC-3′
2.2. Treatment of cultures
RGC-5 cells were maintained in Dulbecco’s modiﬁed Eagle’s
medium (D-MEM) supplemented with 10% foetal bovine serum,
25 mM glucose, 100 U/mL penicillin, and 100 g/mL streptomycin,
and kept in a humidiﬁed atmosphere of 95% air and 5% CO2
at 37 ◦C. Doubling time of these cells was approximately 24 h.
Conﬂuent cultures of RGC-5 cells from 75 cm2 ﬁlter-capped cell
culture ﬂasks were generally passaged at a ratio of approximately
1:6 to give a cell density of approximately 4–5 × 104 cells/ml.
One hundred microlitres of these cells were placed in indi-
vidual CellPlusTM 96-well plates or alternatively in 6-well
plates for protein (electrophoresis/Western blotting) and mRNA
analyses.
For viability studies, cells were allowed to settle in the 96-well
plates for 24 h, then pre-treated for 1 h with a deﬁned substance
(e.g., rapamycin) or vehicle, before exposure to insults of CoCl2
or blue light (250 lux, 400 nm), generally for 24 h before analysis.
The light insult was delivered by a collection of LEDs that were
arranged so that they ﬁtted directly over the wells of 6-well plates,
and placed at speciﬁc distances above the cell cultures to produce
the desired intensities. The light source produced no detectable
change in temperature of the cell culture medium for a period of up
to 96 h.
2.3. Analysis for cell death by ﬂuorescein diacetate (FDA) and
propidium iodide (PI)
Cell death was  measured by incubating cells on coverslips with
5 M of FDA for 2 min  and 3 M of PI for 30 min  at room tempera-
ture. Cells were then washed once with phosphate buffered saline
(PBS) and examined under ﬂuorescence microscopy (Schramm
et al., 1990).
2.4. Localisation of ROS
The dye 2
′
,7
′
-dihydroethidium (DHE) was used to localise reac-
tive oxygen species (Carter et al., 1994). This assay is based on
the fact that non-ﬂuorescent DHE can passively enter living cells,
where it can be oxidised by the superoxide anion or hydrogen
peroxide to generate ethidium bromide, which binds to DNA and,
when excited, emits red ﬂuorescence that is proportional to the
intracellular superoxide anion level. Brieﬂy, after different treat-
ments, DHE (10 g/ml) was added to cultures and maintained in
the dark for 30 min. Therafter, red ﬂuorescent ROS was  detected by
epiﬂuorescence microscopy.
2.5. Apoptosis assayThe APOPercentage assay used was based on the movement of
phosphatidylserine and detection in cell membranes. Brieﬂy, 5 l of
APOPercentage Dye was added to 96-well plates and left for 30 min
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Fig. 1. Localisation of RTP801 immunoreactivity in sections of mouse, rat and human retinas (middle images in each case). Control sections (left images in each case) and
sections of retina processed to detect RTP801 immunoreactivity were also stained with DAPI (right images in each case) to show the localisation of the outer nuclear (ONL),
inner  nuclear (INL) and ganglion cell (GCL) layers. Most of the RTP801 immunoreactivity was located in the GCL, especially in the mouse and rat retinas. Some speciﬁc RTP801
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dmmunoreactivity was  also located in the INL and other retinal layers, particularly i
TP801  and DAPI (images on the right in each case).
t 37 ◦C. After incubation, the medium was removed and the cells
ashed twice with PBS before viewing by light microscope.
.6. Cell count
Cultures were ﬁxed in 4% paraformaldehyde for 15 min  and
ashed in PBS. DAPI was added to identify individual cells and
hotographed using an inverted Leica DMI6000B ﬂuorescence
icroscope (Leica Microsystems). Images were taken using a mag-
iﬁcation to allow for the number of cells in an area of 9 mm2 to
e determined. For each culture, seven replicate ﬁelds of cells were
etermined using the software ImageJ 1.46r.uman retina. This can be clearly seen when comparing sections processed for both
2.7. RTP801 extraction quantiﬁcation by real-time polymerase
chain reaction (PCR)
Total RNA was isolated from RGC-5 cells and also rat and mouse
eye tissues using a PureLink RNA puriﬁcation kit, which included
DNase treatment. Purity of RNA samples was checked by analysis
of A260/A280 ratios and the RNA concentration was  determined
spectrophotometrically. First-strand cDNA was synthesised from
0.5 g of total RNA, using a High Capacity RNA-to-cDNA Master Mix
following the manufacturer’s instructions. The reverse transcrip-
tion step was carried out using the following programme: 25 ◦C for
5 min, 42 ◦C for 30 min  and 85 ◦C for 5 min.
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anglion cells stained positively for Brn3a, but contained little if any RTP801 (arrow
sed  to show the inner nuclear (INL) and inner plexiform (IPL) layers. Note that som
Primers for RTP801, HO-1 and GFAP were internally referenced
o acidic ribosomal protein (ARP), GAPDH or Brn3a, and designed
sing PrimerBLAST and synthesised by Sigma Aldrich (see Table 1).
xpression levels of mRNA were assessed by relative quantiﬁcation
Ct method) in a 7500 Real-Time PCR thermal cycler (Applied
iosystems), using the Power SYBR Green PCR Master Mix. Cycling
arameters were 95 ◦C for 10 min  to activate DNA polymerase, then
0 cycles of 95 ◦C for 15 s and 60 ◦C for 1 min, with a ﬁnal recor-
ing step of 78 ◦C for 20 s to prevent any primer–dimer formation.
ach reaction was run in triplicate and dissociation curves were
onstructed to ensure only a single product was ampliﬁed. Data
ere analysed with the SDS 1.4 software (Applied Biosystems).
.8. RNA interference methodology or siRNA
The culture medium of RGC-5 cells (seeded at 5 × 104 cells/ml)
as changed after 16 h with transfection medium. The trans-
ection medium lacked serum and antibiotics and consisted of
ipofectamine RNAiMAX with 50 nM siRNA (dissolved in OPTI-
EM  medium) or without siRNA (mock). After 4 h, the transfection
edium was removed and replaced with culture medium lack-
ng antibiotics. After an additional 6 h, the cells were used
ig. 3. Fig. 3A shows RTP801 mRNA levels in the retina and lens of mice and rats and al
ig.  3B shows Western blots, where equivalent amounts of extracts from rat and mouse ti
ctin  antibodies. The RTP801 antibody recognised two species, 35 kDa and 28 kDa, in the s, in ganglion cells because of its co-localisation with Brn3a (arrow head). Some
image on the right shows the co-localisation of RTP801 and Brn3a, where DAPI was
PI-positive cells in the GCL (open arrow) did not stain for either RTP801 or Brn3a.
for various studies when the down-regulation of mRNA was
approximately 70–80%. To apply siRNA, ON-TARGET plus SMART
pool, mouse DDIT4 or RTP801 (Thermo Scientiﬁc Dharmacon),
a pool of four different target sequences were used. Controls
routinely were mock transfections rather than ON-TARGET plus
Non-targeting pool transfections, as they gave similar results.
2.9. Immunocytochemistry
RGC-5 cell cultures and retinas were ﬁxed with 4%
paraformaldehyde for 15 min  and 2 h respectively, and then
washed in PBS. Retinas were cryopreserved in sucrose and 10-m
frozen sections produced. Cultures of retinal sections were next
permeabilised with PBS/0.1% Triton (PBST) followed by exposure
to goat serum (10% in PBST) for 60 min. Sections and cultures
were then incubated overnight with primary antibodies (4 ◦C),
washed with PBS and exposed to appropriate secondary antibodies
conjugated to Alexa Fluor 488 or Alexa Fluor 594 (1:300) for 2 h. In
some instances, DAPI (0.2 g/ml) was added to a wash solution of
PBS and mounted in Dako Flourescence mounting medium (Dako,
Inc). Images showing the localisation of RTP-801, HO-1, GFAP and
Brn3a immunoreactivity were obtained using a Leica DM6000B
ﬂuorescence microscope (Leica Microsystems).
so RGC-5 cells, all relative to GAPDH. Results are mean values ± SEMs where n = 4.
ssues (retina and kidney) were fractionated and samples processed with RTP801 or
kidneys, but only the 28-kDa form in the retinal samples.
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Fig. 4. GFAP (A1 and A2), RTP801 (B1 and B2) and HO-1 (C1 and C2) immunoreactivities in rat retina injected with vehicle (A1, B1 and C1) or CoCl2 (100 M)  (A2, B2 and C2).
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owever, no signiﬁcant alteration in the intensity or RTP801 immunoreactivity in t
.10. Western blot analysis
A cocktail lysis buffer that contained phosphatase and protease
nhibitors (Sigma, Aldrich) was used to extract proteins from RGC-5
ultures (approximately 1 ml  per 50 volume ﬂask of conﬂuent cells)
nd ocular tissues (approximately 1 ml/10 mg  of tissue). Extraction
as carried out by homogenisation followed by freeze/thawing,
omogenisation (for ocular tissues) and sonication. Protein con-
ent was then determined using a Bicinchoninic acid protein kit
Sigma–Aldrich). Deﬁned amounts of protein extracts and sample
uffer (2 M Tris/HCl, pH 6.8, containing 8% SDS, 40% glycerol, 8%
ercaptoethanol, and 0.002% bromophenol blue) were then mixed
ogether and immediately heated for 5 min  at 95 ◦C.
Equal amounts of proteins were fractionated by electrophoresis
sing 10% polyacrylamide gels containing 0.1% SDS, as described
y Laemmli (1970). Proteins were transferred to nitrocellulose and
lots incubated overnight at 4 ◦C with various primary antibodies.ulated in the retina, being located primarily in Müller cells and astrocytes (arrows).
glion cells (arrow heads) was observed in the CoCl2-treated tissues.
Detection was then performed with appropriate biotinylated sec-
ondary antibodies. The ﬁnal nitrocellulose blots were developed
with a 0.016% (w/v) solution of 3-amino-9-ethylcarbazole (AEC) in
50 mM sodium acetate (pH 5.0) containing 0.05% (v/v) Tween-20
and 0.03% (v/v) H2O2. The colorimetric reaction was  stopped with
0.05% sodium azide/PBST solution and the blot recorded using the
image acquisition system, Fusion FX7.
2.11. Intravitreal injection of CoCl2
Adult Wistar rats (200–250 g in weight, on average) were
anaesthetised by intraperitoneal injection of a mixture of
ketamine/xylacine. A few drops of oxybuprocaine were applied to
act as a local anaesthetic. Five microlitres of 10 mM CoCl2 (giving a
vitreal concentration of approximately 100 M)  or vehicle (DMSO)
were then injected over 30 s periods into the vitreous humour using
a Hamilton syringe. Two days after the intraocular injections, the
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aig. 5. Expression of GFAP (A), HO-1 (B) and RTP801 (C) mRNAs relative to GAPD
here  vehicle was  injected. There was an up-regulation of GFAP (signiﬁcant) and H
f  RTP801 mRNA relative to Brn3a occurred in retinas where CoCl2 was injected. Re
nimals were sacriﬁced, their eyes enucleated and placed in 4%
araformaldehyde for 2 h or their retinas dissected and preserved in
ppropriate conditions for analysis by Western blotting and qPCR.
rozen sections of ﬁxed eyes were produced and subsequently
rocessed for immunohistochemistry.
ig. 6. Double “staining” of control RGC-5 cells for RTP801 and OXPHOS (A1, A2, A3) or A
ctivity (A1), AIF immunoreactivity (B1) and the mitochondrial marker OXPHOS (A2, B2
taining  of RTP801 and OXPHOS clearly showed that RTP801 sometimes, but not alway
lways occurred (B3). (For interpretation of the references to color in this ﬁgure legend, tetinas from rats injected intraocularly with CoCl2, compared with control retinas
ot signiﬁcant), but not of RTP801. However, a statistically signiﬁcant up-regulation
are mean values ± SEMs where n = 5. *p < 0.05 calculated by t-test analysis.
2.12. Statistical analysisData, unless stated otherwise, were analysed for signiﬁcance
using a t-test and one-way analysis of variance (ANOVA), followed
by a Bonferroni multiple-comparison test. They are expressed as a
IF (B1, B2, B3) in conjunction with the nuclear dye DAPI (blue). RTP801 immunore-
) displayed a similar punctate appearance in the cytoplasm of RGC-5 cells. Double
s, associated with OXPHOS (A3). By contrast, a co-localisation of AIF and OXPHOS
he reader is referred to the web version of this article.)
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Fig. 7. The upper panels are from RGC-5 cells exposed to blue light (600 lux for 12 h), while the lower panels show cells kept in the dark. Blue light caused an enhanced
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ight  was  completely reduced in siRNA-transfected cells in which RTP801 was down
F  and H). Moreover, expression of RTP801 was very low in cells kept in the dark (E
ean percentage of the control value plus SEM. p < 0.05 was con-
idered signiﬁcant.
. Results
Fig. 1 shows the localisation of RTP801 immunoreactivity in
ouse, rat and human retinas. RTP801 immunoreactivity was
articularly strong in cells located in the ganglion cell layer of
ouse and rat retinas and, to a lesser extent, human retina. Somemmunoreactivity was also noted in the inner nuclear layer of all
etinas, with traces in the other retinal layers too. Double staining
f rat retinal sections suggested that many of the cells express-
ng the ganglion cell marker Brn3a also contained RTP801 (Fig. 2).
ig. 8. The upper panels are from RGC-5 cells exposed to CoCl2 (500 M for 12 h), while t
f  RTP801 (A) and an increased number of dead cells (appearing red in a dead/live assay) (
educed in cells transfected by siRNA to down-regulate RTP801 (B and D), and unaffecte
TP801  was  very low in control cells (E) with very few dead cells being present (G). (For 
o  the web version of this article.)/live assay) (C), when compared with cells in the dark (E and G). This effect of blue
lated (B and D), and unaffected in cells with mock-transfection and kept in the dark
 very few dead cells being present (G).
RTP801 was  therefore primarily located in ganglion cells in the rat
retina. However, not all Brn3a-positive cells contained RTP801 and
some cells in the ganglion cell layer expressed neither Brn3a nor
RTP801.
Fig. 3 shows real-time PCR and Western blot data, conﬁrming
the presence of RTP801 in both the retina and lens of rats and mice.
RTP801 has been reported to occur as two  variants with molecu-
lar weights of 35 and 28 kDa (Shoshani et al., 2002). Western blot
studies conﬁrmed that this was  the case in mouse and rat kidney,
but in the retinal samples, only the 28-kDa species was prominent
(Fig. 3B). As shown in Fig. 3A, RTP801 (relative to GAPDH) was more
concentrated in the retina of both rats and mice, compared with
their lens.
he lower panels show control cells (vehicle). CoCl2 caused an enhanced expression
C) when compared with control cells (E and G). This effect of CoCl2 was completely
d in control cells that were mock-transfected (F and H). Moreover, expression of
interpretation of the references to color in this ﬁgure legend, the reader is referred
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Fig. 9. Western blots where equivalent amounts of extracts from RGC-5 cells exposed to either blue light (465–470 nm,  600 lux for 12 h) or CoCl2 (500 M for 12 h) were
fractionated and processed for the expression of RTP801 and actin. Lanes A and 1 show control cells cultured in the dark where trace amounts of RTP801 protein (molecular
weight 28 kDa) occurred when compared to actin (molecular weight 45 kDa). Following blue light (lane 2) or CoCl2 (lane B) exposure, RTP801 expression was clearly elevated.
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*his  increase in RTP801 caused by each insult was  unaffected in cells transfected wit
lanes  4 and D). By contrast, in transfected siRNA cells where RTP801 was down-reg
ttenuated.
The inﬂuence of chemical hypoxia (intravitreal injection of
oCl2) on rat retinal RTP801, GFAP and HO-1 expression is shown
n Fig. 4. Intravitreal injection of CoCl2 increased GFAP and HO-
 expression, which was observed primarily in the Müller and
strocyte glial cells. This was conﬁrmed by real-time PCR stud-
es, where, relative to GAPDH, retinal GFAP (Fig. 5A) and HO-1
Fig. 5B) mRNA levels were signiﬁcantly elevated by CoCl2. By
ontrast, chemical hypoxia did not have a clear effect on the nor-
al  RTP801 immunoreactivity (Fig. 4), supported by the ﬁnding
hat the relative RTP801/GAPDH mRNA levels were statistically
naffected (Fig. 5C). However, when comparing RTP801 mRNA
evels with that of Brn3a, a signiﬁcant up-regulation of RTP801
ccurred in CoCl2-treated retinas (Fig. 5D). Thus, it appears that
TP801 is up-regulated in stressed Brn3a cells in the process of
ying because of CoCl2 treatment.
RTP801 immunoreactivity exhibited an uneven punctate cyto-
lasmic distribution in RGC-5 cells, particularly in cells stressed by
lue light or CoCl2, suggesting a possible mitochondrial localisation.
owever, double “staining” of RGC-5 cells by comparing the local-
sation of RTP801 immunoreactivity, the mitochondrial protein AIF,
ig. 10. Relative expression of RTP801 to GAPDH mRNA in control and cells transfected w
 period of 24 h. Compared with the control cells maintained in the dark, blue light (465
elative to GAPDH, with the inﬂuence of blue light and CCCP being particularly impressiv
TP801. Importantly, RTP801 mRNA level was not changed in siRNA-transfected cells by 
ept  in the dark. Results are mean values ± SEMs, where cells were siRNA transfected on f
*p  < 0.05) were determined by paired t-test analysis.-targeted probes for RTP801 (lanes 3 and C) or mock transfected with lipofectamine
d, the stimulation of the protein by blue light (lane 5) or CoCl2 (lane C) was greatly
and the mitochondrial marker OXPHOS showed that RTP801 only
partly occurred in the mitochondria (Fig. 6). This appeared to be the
case both in control and stress-induced cells where RTP-801 was
up-regulated.
The up-regulation of RTP-801 in RGC-5 cells induced by blue
light or CoCl2 is shown in Figs. 7–10. Basal amount of RTP801
immunoreactivity in RGC-5 cells maintained in the dark was low
(Figs. 7E and 8E), which was  also reﬂected by the Western blot
analysis (Fig. 9) and mRNA expression assays (relative to GAPDH)
(Fig. 10). RTP801 immunoreactivity (Figs. 7A and 8A), RTP801 pro-
tein (molecular weight 28 kDa) (Fig. 9) and RTP801 mRNA (Fig. 10)
were all elevated in RGC-5 cells in varying amounts after an insult
of blue light or CoCl2.
Up-regulation of RTP801 immunoreactivity in mock-transfected
RGC-5 cells (Figs. 7A and 8A) caused by blue light or CoCl2
was accompanied by increased cell death (Figs. 7C and 8C).
This was signiﬁcantly less in cultures where RTP801 mRNA was
down-regulated by siRNA transfection (Figs. 7A, 7D, 8B and 8D).
Semi-quantitative analysis of the numbers of dead cells determined
in dead/live assays (Figs. 7C, 7D, 8C and 8D and Fig. 11) clearly
ith siRNA to down-regulate RTP801, following exposure to various conditions for
–470 nm,  600 lux), CCCP (10 M)  and CoCl2 (500 M)  all increased RTP801 levels
e. Signiﬁcantly, red light (625–635 nm,  1000 lux) did not cause an up-regulation of
any of the insults and was decreased relative to the level of RTP801 in control cells
our different occasions and analysed in duplicate. Signiﬁcant differences (*p < 0.01,
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Fig. 11. Number of dead cells in mock (controls) or RTP801 siRNA-transfected cultures exposed to blue light or CoCl2, as described in Figs. 7 and 8. To detect dead cells,
ﬂuorescein diacetate and propidium iodide were added to cultures, resulting in dead cells appearing red in colour. There were no dead cells in cultures maintained in the
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iark.  However, following exposure to blue light or CoCl2, the numbers of dead cel
iRNA-transfected cultures. A 20× objective was  used to count the number of dead 
veraged for each experiment or culture. Results are means ± SEM for ﬁve separate
emonstrated that blue light and CoCl2 killed a signiﬁcantly greater
umber of cells in mock transfected cultures (Figs. 7C and 8C) than
n cells where RTP801 mRNA was down-regulated (Figs. 7D and 8D).
The effectiveness of the siRNA transfection methodology to
own-regulate RTP801 mRNA in RGC-5 cells is shown in Fig. 10.
ere, the effect of various insults (blue light, red light, the
itochondrial un-coupler CCCP and CoCl2) on mock-transfected
ultures was compared with siRNA-transfected RGC-5 cultures.
ompared with untreated control cells, the mitochondrial un-
oupler CCCP, blue light and CoCl2 all signiﬁcantly elevated RTP801
RNA levels, which was not the case for siRNA-transfected cells. It
s noteworthy that RTP801 mRNA levels were lower in the control
iRNA-transfected cells in red light than mock-transfected cells in
he dark.
ig. 12. The upper panels show cultures exposed to CoCl2 or rapamycin for 24 h and s
he  cultures exposed to CoCl2 gave an intense red ﬂuorescence for ROS (arrows), associ
xpression of ROS. The lower panels show cultures stained for phosphatidylserine by th
taurosporine (1 M) stained positively for phosphatidylserine (arrows) and those attac
ere  very similar in appearance to control cultures, with the odd cell in both cultures sta
n  this ﬁgure legend, the reader is referred to the web  version of this article.)ock transfected cultures were greatly enhanced, which was  signiﬁcantly lower in
ells in a randomly chosen ﬁeld. The numbers of dead cells in ﬁve visual ﬁelds were
iments, **p < 0.01 by Student’s un-paired t-test.
Rapamycin is not toxic and has neuroprotective characteristics,
even at concentrations lower than 10 M.  Exposure of RGC-5 cells
to rapamycin for 24 h did not induce apoptosis or ROS formation,
when compared with the respective inﬂuence of staurosporine or
100 M CoCl2 (Fig. 12). Moreover, rapamycin, unlike CoCl2, did
not cause fragmentation of cell nuclei, an indicator of cell death
(Fig. 13). However, rapamycin, in a concentration-dependent man-
ner, attenuated the negative effect of CoCl2 on the survival of RGC-5
cells in culture, as did epigallocatachin gallate (EGCG) over 24 h
(Fig. 15). Signiﬁcantly, CoCl2 also stimulated RTP801 expression in
RGC-5 cells over the same time period, which was  attenuated by
both EGCG and rapamycin (Fig. 14). EGCG has a number of charac-
teristics that are associated with it being able to attenuate a variety
of negative effects on RGC-5 cells (e.g., Ji et al., 2011). Rapamycin
tained for ROS using the dye DHE. Compared with control cultures, most cells in
ated with their nuclei. By contrast, cells exposed to rapamycin showed very little
e APOPercentage method for apoptosis. A number of cells in cultures exposed to
hed to the substrate exhibited shrinkage. By contrast, cells exposed to rapamycin
ining for phosphatidylserine (arrows). (For interpretation of the references to color
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Fig. 13. RGC-5 cultures were exposed to CoCl2 or rapamycin for 24 h and then viewed by phase contrast microscopy in the absence and presence of DAPI, which stains nuclei
blue.  Compared with control cultures and cultures exposed to rapamycin, CoCl2 caused a fragmentation of nuclei (arrows), which occurs during the death process.
Fig. 14. The upper panels show RTP801 immunoreactivity in RGC-5 cultures exposed to rapamycin or CoCl2 either alone or in combination with EGCG and rapamycin for
24  h. The lower panels show the same cultures exposed to DAPI to reveal cell nuclei (blue). The level of RTP801 immunoreactivity in control cultures was low and increased
signiﬁcantly in response to CoCl2, resulting in approximately 35% of the cells dying (see Fig. 15). Signiﬁcantly, EGCG and rapamycin both nulliﬁed the elevation in the
RTP801 expression induced by CoCl2 and consequently, attenuated cell death (see Fig. 15). Baseline levels of RTP801 immunoreactivity were unaffected by rapamycin. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the web  version of this article.)
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Fig. 15. Rapamycin nulliﬁed the negative effect of 300 M CoCl2 on RGC-5 cell
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phorylation of Akt at Thr308 (Malagelada et al., 2006). Such
F
s
*ssessed using DAPI to count the number of cells in a number of deﬁned visual ﬁelds
rom ﬁve different cultures. Results are mean values ± SEMs where n = 5. **p < 0.05,
**p  < 0.001 calculated by t-test analysis.
id not stimulate RTP801 immunoreactivity (Fig. 14) and impor-
antly, real-time PCR analysis showed that rapamycin caused a
oncentration-dependent down-regulation of RTP801 mRNA over
4 h (Fig. 16A). However, rapamycin also increased mTOR mRNA
evels (Fig. 16B). This observation is difﬁcult to explain in the con-
ext of rapamycin’s known effect on mTOR (Bové et al., 2011), but
ight reﬂect the known actions of rapamycin on protein synthesis
Rüegg et al., 2007).
. Discussion
The present study provides evidence for the occurrence of
TP801 protein and mRNA in the rodent retina. Moreover, RTP801
mmunoreactivity occurs in different parts of the retina, with its
ocalisation clearly evident in ganglion cells of the rat, mouse and,
o a lesser extent, human retina. These observations are partly
upported by the report of Brafman et al. (2004), where in situ
ybridisation of RTP801 mRNA showed signals located in all retinal
ayers, with hypoxia inducing an elevation in these signals in the
ig. 16. Expression of RTP801 and mTOR mRNA levels relative to GAPDH in RGC-5 cells
igniﬁcant decrease and increase in RTP801 and mTOR, respectively. Results are mean v
**p  < 0.001) were determined by Student’s un-paired t-test.rch Bulletin 98 (2013) 132– 144
outer portion of the inner retinal layer. Our immunohistochemi-
cal ﬁnding that RTP801 occurred strongly in retinal ganglion cells
could be important as it suggests that targeting RTP801 might
help to preserve ganglion cell function in optic neuropathies like
glaucoma. RTP801 is known to be induced during oxidative stress,
hypoxia, DNA damage and energy depletion (Ellisen et al., 2002;
Shoshani et al., 2002; Sofer et al., 2005; Wang et al., 2003), processes
all likely to be associated with ganglion cell death in glaucoma
(Calkins, 2012; Osborne, 2008, 2010; Osborne et al., 2006). Signif-
icantly, a body of evidence shows that in neuronal degeneration
models of Parkinson’s disease, RTP801 is induced, while its down-
regulation reduces the rate of apoptosis (Malagelada et al., 2006,
2008, 2010; Marras and Lang, 2008). However, the functional con-
sequences of RTP801 induction can vary considerably in different
situations. For instance, induced RTP801 can protect cells from apo-
ptosis associated with oxidative stress (Shoshani et al., 2002), but
promotes death in post-mitotic neurons (Malagelada et al., 2008;
Shoshani et al., 2002). This is probably because RTP801 participates
in a variety of functions such as neurogenesis, differentiation and
migration, as described in cortical development (Malagelada et al.,
2011). Such information suggests that care needs to be taken when
examining the functional role of RTP801 in mature neurones in situ
as opposed to assessing cells in culture.
Intravitreal injection of CoCl2 clearly caused retinal toxicity, as
indicated by an up-regulation of HO-1 and GFAP, both in terms
of mRNA (in relation to GAPDH) and immunoreactivity. However,
there was no clear change in RTP801 immunoreactivity or mRNA
levels (relative to GAPDH) in these cases. Despite this ﬁnding, we
believe that CoCl2 treatment does result in RTP801 mRNA being
induced in stressed retinal ganglion cells, as this was elevated when
compared with Brn3a mRNA.
It is known that RTP801 affects the activation of mTOR (mam-
malian target of rapamycin), an evolutionarily conserved kinase
that affects a variety of cellular responses, including protein
translation, energy use, proliferation, differentiation and survival
(Bové et al., 2011; Corradetti et al., 2005; Jacinto and Lorberg,
2008; Schwarzer et al., 2005). Moreover, it has been reported
that rapamycin protects neurons from death in both cellular and
animal toxin models of Parkinson’s disease (Malagelada et al.,
2010), as well as when RTP801 is knocked down through phos-information formed the basis of our studies, which aimed to
determine whether rapamycin/RTP801 actions on mTOR pro-
tected RGC-5 cells in culture from an insult of CoCl2. We
 following exposure to rapamycin for 24 h. Both 1 and 10 M rapamycin caused a
alues ± SEM of four different cultures; signiﬁcant differences (*p < 0.05, **p  < 0.01,
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ecognise that such information might not necessarily trans-
ate to what occurs in situ or during ganglion cell death in
laucoma.
Low amounts of RTP801 immunoreactivity were observed in
he cytoplasm of unstressed RGC-5 cells, where it was  only partly
ssociated with mitochondria (Fig. 6), as deduced by comparison
ith the localisation of the mitochondrial proteins AIF and OXPHOS
del Olmo-Aguado et al., 2012; Osborne et al., 2008). However,
hen RGC-5 cells were exposed to CoCl2 or blue light, a signiﬁcant
ncrease in cytoplasmic RTP801 immunoreactivity was noted (see
igs. 7A and 8A). The presence of RTP801 within the mitochondria
inks mitochondrial functions and reduced ROS production (Horak
t al., 2010). Signiﬁcantly, we demonstrated that blue light or CoCl2
nduced RTP801 expression in RGC-5 cells and that this process was
ssociated with cell death, which in turn was drastically decreased
hen RTP801 was down-regulated. Such data provide strong sup-
ort for the idea that CoCl2 or blue light-induced cell death of RGC-5
ells involves an initial up-regulation of RTP801.
Blue light has a negative effect on RGC-5 cell survival, but red
ight does not (del Olmo-Aguado et al., 2012; Osborne et al., 2008;
sborne, 2010). Indeed, evidence exists to suggest that red light
avelengths from far red to near-infrared, i.e.,  between 600 and
000 nm,  can attenuate a variety of injuries to the retina (Albarracin
t al., 2011; Albarracin and Valter, 2012; Begum et al., 2013). The
bservation (Fig. 10) that RTP801 mRNA levels in mock-transfected
ells were unaffected by red light, but signiﬁcantly elevated by blue
ight provides further support for the “protective” effect of red light.
To deduce whether rapamycin counteracted the effects of blue
ight or CoCl2 on RGC-5 cells, we initially examined how mTOR
nd/or RTP801 mRNAs were affected by rapamycin. Rapamycin
uppressed RTP801 mRNA expression, which was consistent with
he idea of it acting as a neuroprotectant. However, the ﬁnding that
apamycin increased mTOR mRNA level was inconsistent with the
dea that rapamycin attenuates the activity of RTP801. It should
e noted that rapamycin does not impair the kinase activity of
TOR per se,  but disrupts the assembly of mTOR protein com-
lexes (Bové et al., 2011). Moreover, rapamycin has been described
o have a variety of additional inﬂuences, which include inhibi-
ing the translation of mRNAs encoding ribosomal proteins and
longation factors (Terada et al., 1994), inhibiting 70 kDa S6 pro-
ein kinases (Chung et al., 1992) and stimulating BDNF expression
Schratt et al., 2004). It is also possible that a feed-back mecha-
ism exists between RTP801 production, mTOR suppression and
kt signalling. Rapamycin is also known to cause feedback activa-
ion of Akt signalling through IGF-IR-dependent mechanisms (Wan
t al., 2007).
Our results on RGC-5 cells are in general agreement with the
eports from others (Dudel et al., 1997; Franke et al., 1997a; Franke
t al., 1997b; Malagelada et al., 2010), indicating that inhibition of
TP801 production through the activation of mTOR maintains neu-
onal survival. Even at a concentration of 10 M,  rapamycin did not
ause any signs of toxicity or proliferation of RGC-5 cells (data not
hown). Based on these ﬁndings, we suggest that rapamycin may
lso have the potential to protect non-proliferating retinal gan-
lion cells. Interestingly, survival of retinal ganglion cells in situ
s enhanced by the activation of Akt signalling (Levkovitch-Verbin
t al., 2007; Manabe and Lipton, 2003; Nakazawa et al., 2005), while
hosphorylation of Akt at Thr308 (mimicked by rapamycin) has
lso been proposed to be a pro-survival stimulus (Malagelada et al.,
010). One future aim is therefore to investigate whether NMDA-
nduced toxicity of rat retinal ganglion cells in situ can be blunted
y rapamycin.In conclusion, our study shows that RTP801 occurs in the rodent
etina, speciﬁcally in ganglion cells. Studies on RGC-5 cell cultures
emonstrated that an up-regulation of RTP801 was associated with
ell death. By contrast, reduced expression of RTP801, inducedrch Bulletin 98 (2013) 132– 144 143
either by siRNA transfection or by rapamycin, was  associated with
cell survival. We suggest that rapamycin with its non-toxic charac-
teristics might be used to directly affect RTP801 levels in retinal
ganglion cells in situ and in the process, protect them from the
insults that might occur in glaucoma.
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